Centenara Labs
VC Fund
Schlieren, Switzerland
Centenara Labs is a VC fund in Schlieren focused on Medical and Health Care. Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Centenara Labs invests in
Stages Centenara Labs invests in
Countries Centenara Labs invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bob Silverman
|
|||
4 more contacts available
Investment Focus
Industry
- Medical 1 (25%)
- Health Care 1 (25%)
- Therapeutics 1 (25%)
- Biotechnology 1 (25%)
Stage
- Series A 1 (25%)
- Series B 1 (25%)
Country
- Belgium 1 (25%)
- United States 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bob Silverman
Chief Business Officer
|
Chief Business Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Endogena
|
Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders.The company implements innovation in the field of regenerative medicine. Their sciencecombines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases. | $21M / Series A / Dec 13, 2021 | |
Rejuvenate Biomed
|
Rejuvenate Biomed is a biomedical company researching the biology of aging & applying this knowledge to identify safe and well tolerated drugs to maintain and restore our natural cell resilience capacity improving the respons to age-related diseases. | $18.1M / Series B / Oct 12, 2021 | |
|
Rejuvenate Biomed
|
Rejuvenate Biomed is a biomedical company researching the biology of aging & applying this knowledge to identify safe and well tolerated drugs to maintain and restore our natural cell resilience capacity improving the respons to age-related diseases. | $18.1M / Series B / Oct 12, 2021 | |
|
Endogena
|
Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders.The company implements innovation in the field of regenerative medicine. Their sciencecombines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases. | $8M / Series A / Jan 28, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Centenara Labs invest in?
Centenara Labs invests primarily in Medical, Health Care and Therapeutics startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Centenara Labs?
Public channels for Centenara Labs include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Centenara Labs?
The team at Centenara Labs includes Bob Silverman (Chief Business Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
